Insider Transactions in Q4 2022 at Black Diamond Therapeutics, Inc. (BDTX)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
Dec 22
2022
|
Fang Ni |
BUY
Open market or private purchase
|
Direct |
36,363
+22.48%
|
$36,363
$1.28 P/Share
|
Dec 21
2022
|
Fang Ni |
BUY
Open market or private purchase
|
Direct |
20,000
+18.34%
|
$20,000
$1.29 P/Share
|
Dec 16
2022
|
Robert Alexander Ingram |
BUY
Grant, award, or other acquisition
|
Direct |
9,375
+17.95%
|
$9,375
$1.5 P/Share
|
Dec 16
2022
|
Wendy L Dixon |
BUY
Grant, award, or other acquisition
|
Direct |
7,167
+30.65%
|
$7,167
$1.5 P/Share
|
Dec 16
2022
|
Mark A. Velleca PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,424
+28.48%
|
$8,424
$1.5 P/Share
|
Dec 16
2022
|
Ali Behbahani |
BUY
Grant, award, or other acquisition
|
Direct |
7,917
+22.04%
|
$7,917
$1.5 P/Share
|
Oct 31
2022
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
99,801
+1.82%
|
$199,602
$2.25 P/Share
|
Oct 28
2022
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
172,974
+3.17%
|
$345,948
$2.18 P/Share
|
Oct 27
2022
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
191,678
+3.62%
|
$191,678
$1.87 P/Share
|
Oct 21
2022
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
87,850
+1.76%
|
$87,850
$1.51 P/Share
|
Oct 20
2022
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
53,734
+1.1%
|
$53,734
$1.42 P/Share
|
Oct 19
2022
|
Growth N V Biotech |
BUY
Open market or private purchase
|
Direct |
77,689
+1.6%
|
$77,689
$1.32 P/Share
|